Skip to content

Nanopath

2 viewers · 30d

Total raised

$5.3M

1 filing since 2025 · latest Debt filed

Cumulative raised
LAST ROUND
Debt · $5.3M
ROUNDS
1
INVESTORS
5
FOUNDED
N/A
HQ
Cambridge, MA
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
2

AI overview

Updated

Nanopath Inc is a pioneering molecular diagnostics company headquartered in Cambridge, Massachusetts. The company is dedicated to revolutionizing traditional medical testing approaches, particularly in the domain of women's health, by developing rapid and accurate diagnostic solutions.

What sets it apart

Nanopath is distinguished by its ability to deliver detailed diagnostic information during a single medical visit, thus significantly enhancing the efficiency and effectiveness of healthcare delivery in women's health.

Funding history

1 round
DebtJan 24, 2025
Form D
+$5.3M$5.3M total

Latest SEC filings

via EDGAR · CIK 0001940981
Form D · Jan 24, 2025View on EDGAR

Products

1 tracked

Molecular Diagnostic Technology

Diagnostic technology

Nanopath's molecular diagnostic technology offers rapid and comprehensive testing solutions designed specifically for women's health. This platform allows healthcare providers to obtain clinically actionable insights quickly, aiding in more prompt and accurate health assessments.

  • Rapid testing capabilities
  • Detailed diagnostic results
  • Designed for use within a single office visit

Links

SEC EDGAR filings